MR Solutions Inc.

MR Solutions Inc., a Massachusetts-based for-profit manufacturer of magnetic resonance imaging and positron emission tomography systems, operates exclusively as a prime contractor delivering specialized medical imaging equipment and related maintenance services to federal research and healthcare agencies on a full-and-open basis with no set-aside utilization. The company, headquartered in Acton, Massachusetts, competes primarily under NAICS 334510 (Medical Equipment Manufacturing) and PSC codes spanning analytical laboratory instrument manufacturing and electromedical apparatus manufacturing, with ancillary service work under equipment maintenance and repair codes.

Recent federal work centers on preclinical and clinical MRI and PET/CT imaging systems for research infrastructure. MR Solutions' largest recent award is a $2.18 million firm fixed-price definitive contract with the Food and Drug Administration, awarded September 24, 2024, for an MRI system with post-warranty service and maintenance option periods running through January 31, 2033. A $2.89 million purchase order from Veterans Integrated Service Network 15 (September 28, 2022) provided a large-bore 9.4 Tesla PET/MRI system for traumatic brain injury research. The National Cancer Institute has awarded multiple maintenance contracts, including a $244,510 purchase order (April 1, 2025) for preventive maintenance on an MRS*PET/CT imaging scanner system at the National Institutes of Health Bethesda facility, spanning a 12-month base period with two optional extensions through March 31, 2028.

Customer concentration is split between the National Cancer Institute, which accounts for 11 awards and $1 million in combined potential value, and the Department of Veterans Affairs across multiple Veterans Integrated Service Networks. The VA's Veterans Integrated Service Network 15 anchors the largest single award ($2.9 million) but by count ranks behind the National Cancer Institute. Veterans Integrated Service Networks 8 and 4 contribute three and two awards respectively ($523 thousand and $2.5 million combined potential value). The Food and Drug Administration and multiple VA service networks combine to account for 98% of MR Solutions' recent award portfolio. All 20 recent awards reflect prime contractor positioning; the vendor carries no subcontract footprint in the source data.

Activity has been sparse and uneven. Two awards arrived in 2022, one in 2023, two in 2024, one in 2025, and two in 2026, with a combined potential value of $9.3 million across all federal sources. Four awards with ultimate completion dates in the next twenty-four months carry $3.5 million in combined potential value and face recompete exposure. Eighty-five percent of combined potential value across all awards has been obligated, indicating mature contract execution. The vendor's portfolio reflects a specialized niche in federal medical research — the development and maintenance of advanced imaging systems for preclinical and clinical research at the VA and the National Institutes of Health — with no broad-based GSA schedule or government-wide vehicle presence and no defense or civilian agency diversification beyond health research customers.

Innovative MRI technology